Striatal Dopamine D1-type Receptor Availability: No Difference from Control but Association with Cortical Thickness in Methamphetamine Users

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2017 Sep 13

PMID 28894300

Citations 13

Authors

K Okita

A M Morales

A C Dean

M C Johnson

V Lu

J Farahi

M A Mandelkern

E D London

Affiliations

Soon will be listed here.

Abstract

Chronic methamphetamine use poses potentially devastating consequences for directly affected individuals and for society. Lower dopamine D2-type receptor availability has been observed in striata of methamphetamine users as compared with controls, but an analogous comparison of D1-type receptors has been conducted only on post-mortem material, with no differences in methamphetamine users from controls in the caudate nucleus and putamen and higher D1-receptor density in the nucleus accumbens. Released from neurons when methamphetamine is self-administered, dopamine binds to both D1- and D2-type receptors in the striatum, with downstream effects on cortical activity. Thus, both receptor subtypes may contribute to methamphetamine-induced alterations in cortical morphology and behavior. In this study, 21 methamphetamine-dependent subjects and 23 healthy controls participated in positron emission tomography and structural magnetic resonance imaging for assessment of striatal D1- and D2-type receptor availability and cortical gray-matter thickness, respectively. Although D2-type receptor availability (BPnd) was lower in the methamphetamine group, as shown previously, the groups did not differ in D1-type BPnd. In the methamphetamine group, mean cortical gray-matter thickness was negatively associated with cumulative methamphetamine use and craving for the drug. Striatal D1-type but not D2-type BPnd was negatively associated with global mean cortical gray-matter thickness in the methamphetamine group, but no association was found between gray-matter thickness and BPnd for either dopamine receptor subtype in the control group. These results suggest a role of striatal D1-type receptors in cortical adaptation to chronic methamphetamine use.

Citing Articles

Neurotoxicity mechanisms and clinical implications of six common recreational drugs.

Wang J, Hao Y, Ma D, Feng L, Yang F, An P Front Pharmacol. 2025; 16:1526270.

PMID: 40034818 PMC: 11873747. DOI: 10.3389/fphar.2025.1526270.

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention.

Volkow N, Blanco C World Psychiatry. 2023; 22(2):203-229.

PMID: 37159360 PMC: 10168177. DOI: 10.1002/wps.21073.

Cortical thickness and related depressive symptoms in early abstinence from chronic methamphetamine use.

Petzold J, Dean A, Pochon J, Ghahremani D, De La Garza 2nd R, London E Addict Biol. 2022; 27(5):e13205.

PMID: 36001419 PMC: 9413352. DOI: 10.1111/adb.13205.

Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography.

Okita K, Matsumoto T, Funada D, Murakami M, Kato K, Shigemoto Y Front Pharmacol. 2022; 13:820447.

PMID: 35645814 PMC: 9130733. DOI: 10.3389/fphar.2022.820447.

Candidate Chinese Herbal Medicine Alleviates Methamphetamine Addiction Regulating Dopaminergic and Serotonergic Pathways.

Ru Q, Xiong Q, Tian X, Xu C, Li C, Chen L Front Mol Neurosci. 2022; 15:874080.

PMID: 35422687 PMC: 9002015. DOI: 10.3389/fnmol.2022.874080.

References

Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L . Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology. 1994; 11(4):245-56. DOI: 10.1038/sj.npp.1380111. View

Tong J, Ross B, Schmunk G, Peretti F, Kalasinsky K, Furukawa Y . Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry. 2003; 160(5):896-903. DOI: 10.1176/appi.ajp.160.5.896. View

Ujike H, Akiyama K, Nishikawa H, Onoue T, Otsuki S . Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration. Brain Res. 1991; 540(1-2):159-63. DOI: 10.1016/0006-8993(91)90503-n. View

Johansson B, Georgiev V, Fredholm B . Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors. Neuroscience. 1997; 80(4):1187-207. DOI: 10.1016/s0306-4522(97)00143-7. View

Jenkinson M, Bannister P, Brady M, Smith S . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002; 17(2):825-41. DOI: 10.1016/s1053-8119(02)91132-8. View

Patkar A, Lundy A, Leone F, Weinstein S, Gottheil E, Steinberg M . Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Subst Abus. 2002; 23(2):105-14. DOI: 10.1080/08897070209511480. View

Bloomfield M, Ashok A, Volkow N, Howes O . The effects of Δ-tetrahydrocannabinol on the dopamine system. Nature. 2016; 539(7629):369-377. PMC: 5123717. DOI: 10.1038/nature20153. View

Mukherjee J, Christian B, Dunigan K, Shi B, Narayanan T, Satter M . Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse. 2002; 46(3):170-88. DOI: 10.1002/syn.10128. View

Fischl B, Salat D, Busa E, Albert M, Dieterich M, Haselgrove C . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002; 33(3):341-55. DOI: 10.1016/s0896-6273(02)00569-x. View

10.

Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H . Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001; 158(8):1206-14. DOI: 10.1176/appi.ajp.158.8.1206. View

11.

Hoddes E, Zarcone V, Smythe H, Phillips R, Dement W . Quantification of sleepiness: a new approach. Psychophysiology. 1973; 10(4):431-6. DOI: 10.1111/j.1469-8986.1973.tb00801.x. View

12.

Fischl B, Sereno M, Dale A . Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999; 9(2):195-207. DOI: 10.1006/nimg.1998.0396. View

13.

Sussner B, Smelson D, Rodrigues S, Kline A, Losonczy M, Ziedonis D . The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2005; 83(3):233-7. DOI: 10.1016/j.drugalcdep.2005.11.022. View

14.

Chomchai C, Chomchai S . Global patterns of methamphetamine use. Curr Opin Psychiatry. 2015; 28(4):269-74. DOI: 10.1097/YCO.0000000000000168. View

15.

Surmeier D, Ding J, Day M, Wang Z, Shen W . D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007; 30(5):228-35. DOI: 10.1016/j.tins.2007.03.008. View

16.

Martinez D, Slifstein M, Narendran R, Foltin R, Broft A, Hwang D . Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology. 2009; 34(7):1774-82. PMC: 2680918. DOI: 10.1038/npp.2008.235. View

17.

Morales A, Kohno M, Robertson C, Dean A, Mandelkern M, London E . Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Mol Psychiatry. 2015; 20(6):764-71. PMC: 4440838. DOI: 10.1038/mp.2015.47. View

18.

Chang L, Cloak C, Patterson K, Grob C, Miller E, Ernst T . Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry. 2005; 57(9):967-74. PMC: 4899039. DOI: 10.1016/j.biopsych.2005.01.039. View

19.

Segonne F, Dale A, Busa E, Glessner M, Salat D, Hahn H . A hybrid approach to the skull stripping problem in MRI. Neuroimage. 2004; 22(3):1060-75. DOI: 10.1016/j.neuroimage.2004.03.032. View

20.

McCabe R, Hanson G, Dawson T, Wamsley J, GIBB J . Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: comparison with tyrosine hydroxylase activity. Neuroscience. 1987; 23(1):253-61. DOI: 10.1016/0306-4522(87)90287-9. View